Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Quinolones Market Heading Into 2029?

The size of the quinolones market has seen a consistent increase in the past few years. The market, valued at $50.05 billion in 2024, is projected to reach $51.89 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.7%. The expansion witnessed in the historic time frame owes to factors like increased demand for and use of antibiotics, regulatory sanctions, extensive research and development, competitive market scenarios, and impending patent expirations.

Anticipated robust expansion is predicted for the quinolones market in the forthcoming years. It’s projected to reach a value of $63.17 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to growth during this period include the emergence of new diseases, modifications in regulations, evolution of global health policies, increasing antibiotic resistance, and extensive market growth tactics. Significant trends during the forecast period encompass the development of new products and alterations in the regulatory environment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Factors Are Pushing The Quinolones Market Forward?

The quinolones market is experiencing substantial growth due to the increasing prevalence of infectious diseases. These illnesses, caused by microorganisms like parasites, bacteria, viruses, and fungi, often require treatment with quinolones. These drugs are particularly effective for bacterial infections such as tuberculosis and urinary tract infections. Data from the Global Tuberculosis Report by Switzerland’s World Health Organization in November 2023 highlighted an increase in fresh TB diagnoses to 7.5 million in 2022, up from 6.4 million in 2021. As a result, this uptick in infectious diseases cases will act as a driver for the quinolones market.

Which Segment Held The Largest Share In The Quinolones Market In 2025?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

How Are Key Trends Driving Expansion In The Quinolones Industry?

The main trend gaining traction in the quinolones market is product innovation. In order to maintain their market standing, many of the significant companies within the quinolones market are putting a heavy focus on creating innovative products. An example of this is when a new drug-resistant tuberculosis treatment, Dovprela, was introduced by the South Korean branch of Viatris, an American pharmaceutical company, in January 2023. For the treatment of adult patients suffering from extensively drug-resistant TB or non-responsive multidrug-resistant TB, Dovprela uses a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL). Due to its potent anti-tuberculosis properties, the drug can cut down the treatment duration from 18-20 months to only 5-6 months.

Which Organizations Are Driving Progress In The Quinolones Industry?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Quinolones Industry?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model